No Data
Shandong Wit Dyne Health (000915.SZ): The controlling shareholder is planning a reorganization and integration.
On January 17th, Gelonghui reported that Shandong Wit Dyne Health (000915.SZ) announced that on January 17, 2025, the company received a notification letter from Shandong State-owned Assets Investment Holding Company (the controlling shareholder of the company's controlling shareholder, Shandong Wit Holding Group Co., Ltd., referred to as "Shandong Guotou Company") regarding the ongoing reorganization and integration planning. Shandong Guotou Company is planning to reorganize and integrate with Shandong Talent Development Group Co., Ltd., which will not lead to a change in the controlling shareholder of the company nor a change in the actual controller of the company.
Shandong Wit Dyne Health (000915.SZ) received shareholding increases of 0.035 million shares from two executives.
Shandong Wit Dyne Health (000915.SZ) issued an announcement that the company received the reports from Director and General Manager Ms. Yang Jie and the Secretary of the Board of Directors Fan...
Shandong Wit Dyne HealthLtd (SZSE:000915) Sheds CN¥452m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Year
Shandong Wit Dyne Health (000915.SZ): The prices of the "Yikexin" vitamins A and D and the "Yikexin" brand children's health food products remain stable.
On December 10, Gelonghui reported that shandong wit dyne health (000915.SZ) stated on the investor interaction platform that the prices of products such as "Ikexin" vitamins A and D and "Ikexin" brand children's health food are stable, with no significant price reductions.
WIT Dyne Health's Unit Gets Registration Certificate for Simethicone Emulsion
Shandong Wit Dyne Health (000915.SZ): Subsidiary La Liga silicone oil emulsion obtained pharmaceutical registration certificate.
Gelonghui November 21st | Shandong Wit Dyne Health (000915.SZ) announced that recently, the company's subsidiary Shandong Dyne Marine Biopharmaceutical Co., Ltd. (referred to as Dyne Pharmaceuticals) has received the "Pharmaceutical Registration Certificate" issued by the National Medical Products Administration (Certificate No.: 2024S02791). The drug is named as Xijia Silicone Emulsion, indicated for: 1. Used to treat discomfort symptoms caused by excessive gas accumulation in the gastrointestinal tract: such as bloating, can also be used postoperatively. 2. Can be used as an adjuvant medication for abdominal imaging examinations (such as X-rays, ultrasound, gastroscopy) and for double contrast display.
We Think Shandong Wit Dyne HealthLtd's (SZSE:000915) Profit Is Only A Baseline For What They Can Achieve
